Evidence map›Paper›PMID 8941652›Full record

ArticleThe Journal of clinical investigation1996

Human primary myoblast cell cultures from non-diabetic insulin resistant subjects retain defects in insulin action.

D B Thompson, R Pratley, V Ossowski

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03665051 (Electrical Stimulation of Human Myocytes in Microgravity), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03665051 active not recruitingnot on this mapstarted 2019, after this paper: background citation

Electrical Stimulation of Human Myocytes in Microgravity: An In Vitro Model to Evaluate Therapeutics to Counteract Muscle Wasting (microG)

TypeobservationalSponsorAdventHealth Translational Research InstituteRan2019 to 2025Enrolled75ConditionsSarcopeniaArmsMuscle Tissue Biopsy, Maximal Oxygen Consumption (V02max)
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

D B ThompsonClinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona 85016, USA. bthompson@phx.niddk.nih.gov
R Pratley
V Ossowski
National Institutes of Health · USNational Institute of Diabetes and Digestive and Kidney Diseases · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin resistance is a predictor of the development of noninsulin-dependent diabetes mellitus (NIDDM) in humans. It is unclear whether insulin resistance is a primary defect leading to NIDDM or the result of hyperinsulinemia and hyperglycemia. To determine if insulin resistance is the result of extrinsic factors such as hyperinsulinemia primary skeletal muscle cell cultures were established from muscle biopsies from Pima Indians with differing in vivo insulin sensitivities. These cell cultures expressed a variety of muscle-specific phenotypes including the proteins alpha-actinin and myosin, muscle-specific creatine kinase activity, and RNA encoding GLUT4, MYF5, MYOD1, and MYOGENIN. Labeled glucose was used to measure the insulin-stimulated conversion of glucose to glycogen in these cultures. The in vivo rates of insulin-stimulated glycogen production (insulin resistance) were correlated with in vitro measures of glycogen production (P = 0.007, r = 0.58). This defect in insulin action is stable in a uniform culture environment and is retained over time. The retention of insulin resistance in myoblast derived cell cultures is consistent with the expression of an underlying biochemical defect in insulin resistant skeletal muscle.

Indexed as

DNA-Binding ProteinsTrans-ActivatorsActininAdultBlotting, NorthernCreatine KinaseDiabetes Mellitus, Type 2Dose-Response Relationship, DrugFluorescent Antibody Technique, DirectGlucoseGlucose Transporter Type 4GlycogenHumansHypoglycemic AgentsIndians, North AmericanInsulinActininCreatine KinaseDNA-Binding ProteinsGlucoseGlucose Transporter Type 4GlycogenHypoglycemic AgentsInsulinMonosaccharide Transport ProteinsMuscle ProteinsMYF5 protein, humanMyoD1 myogenic differentiation proteinMyoD ProteinMyogenic Regulatory Factor 5MyogeninMYOG protein, humanMyosinsRNA, MessengerSLC2A4 protein, humanTrans-Activators

Identifiers

PMID8941652
PMCPMC507685
OpenAlexW2067565448

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.